Value-based care and Medicare Advantage are often heralded as two of healthcare’s most promising strategies for controlling costs, but industry leaders can’t quite tell if they’re actually working. During a
Gilead Sciences is building out its pipeline through a multi-billion dollar deal to acquire Tubulis, a startup with two targeted therapies in clinical testing. While those therapies are in development
Modern healthcare is increasingly powered by data — but much of that data was never designed to reflect half the population. When the data is incomplete or unbalanced, even the
After several uneven years for venture funding, the digital health sector saw a boost in investment during the first quarter of this year. Digital health startups raised $4 billion across
Healthcare is moving toward more direct engagement between brands, providers, and patients. Manufacturer-led access programs are expanding, and large pharmaceutical companies are testing centralized patient portals that combine information, fulfillment,
Healthcare professionals encounter chronic pain in nearly every practice setting. Whether it is the patient in your exam room, a colleague struggling silently, or a family member whose life has
Oral peptide drugs are having a moment. FDA approvals in recent months include the first peptide pills for obesity and plaque psoriasis, each providing an alternative to injectable medications. Pinnacle
AI tools continue to flood the healthcare market, but not every startup will survive the hype cycle. Uma Veerappan, a vice president at Flare Capital Partners, believes the companies achieving
Biogen is acquiring Apellis Pharmaceuticals in a $5.6 billion deal that brings two FDA-approved products commercialized in four indications, all of which are expected to contribute to the revenue growth
In healthcare, we preach infection control, emphasizing hand hygiene, surgical site sterility, and protective equipment. But there’s a silent risk too many hospitals overlook: contamination on lead aprons, which clinicians
